ArticleProceedings of the National Academy of Sciences of the United States of America2024

Type I interferon signaling pathway enhances immune-checkpoint inhibition in KRAS mutant lung tumors.

Fernando Fernández-García et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.